Stress-induced plasticity and functioning of ventral tegmental dopamine neurons

https://doi.org/10.1016/j.neubiorev.2019.10.015Get rights and content
Under a Creative Commons license
open access

Highlights

  • mPFC coordinates VTA-linked emotional-motivational valuation with stress-coping.

  • CRH reduces, while opioids and glucocorticoids increase tonic VTA excitability.

  • VTA-DA neurons degenerate during chronic stress after a transient rise in excitability.

  • VTA-DA neurons are sexual dimorphic.

  • VTA-DA dysfunction is a common substrate for obesity, depression, OCD, and addiction.

Abstract

The ventral tegmental area dopamine (VTA-DA) mesolimbic circuit processes emotional, motivational, and social reward associations together with their more demanding cognitive aspects that involve the mesocortical circuitry. Coping with stress increases VTA-DA excitability, but when the stressor becomes chronic the VTA-DA circuit is less active, which may lead to degeneration and local microglial activation. This switch between activation and inhibition of VTA-DA neurons is modulated by e.g. corticotropin-releasing hormone (CRH), opioids, brain-derived neurotrophic factor (BDNF), and the adrenal glucocorticoids. These actions are coordinated with energy-demanding stress-coping styles to promote behavioral adaptation. The VTA circuits show sexual dimorphism that is programmed by sex hormones during perinatal life in a manner that can be affected by glucocorticoid exposure. We conclude that insight in the role of stress in VTA-DA plasticity and connectivity, during reward processing and stress-coping, will be helpful to better understand the mechanism of resilience to breakdown of adaptation.

Abbreviations

ACTH
adrenocorticotropic hormone
AMPA
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
MPAR
AMPA receptor
BDNF
brain-derived neurotrophic factor
BLA
basolateral amygdala
BNST
bed nucleus striae terminalis
CMS
chronic mild stress
CRH
corticotropin-releasing hormone
CRS
chronic restraint stress
CSDS
chronic social defeat stress
CUS
chronic unpredictable stress
DA
dopamine
DOR
δ-opioid receptor
GABA
γ-aminobutyric acid
GABAR
GABA receptor
GR
glucocorticoid receptor
GSK3
glycogen synthase 3
HPA-axis
hypothalamus-pituitary-adrenal axis
IP3
inositol 1,4,5-triphoshpate
IP3R
IP3 receptor
ISDS
intermittent social defeat stress
KOR
κ-opioid receptor
LTD
long-term depression
LTP
long-term potentiation
mEPSC
miniature excitatory postsynaptic currents
mGluR
metabotropic glutamate receptor
MOR
μ-opioid receptor
mPFC
medial prefrontal cortex
MR
mineralocorticoid receptor
mTOR
mammalian target of rapamycin
N/OFQ
nociceptin/orphanin FQ
NAc
nucleus accumbens
NE
norepinephrine
NMDA
N-methyl-D-aspartate
NMDAR
NMDA receptor
NO
nitric oxide
NOPR
nociceptin/orphanin FQ receptor
PAG
periaquaductal grey
PI3K
phosphatidylinositol 3 kinase
PKA
protein kinase A
PKC
protein kinase C
PLCγ
phospholipase C-γ
POMC
pro-opiomelanocortin
PPTg
pedunculupontine tegmentum
PVN
paraventricular nucleus
TH
tyrosine hydroxylase
vHipp
ventral hippocampus
VP
ventral pallidum
VTA
ventral tegmental area

Keywords

Ventral tegmental area
Mesocorticolimbic system
Dopamine
Stress
Glucocorticoids
CRH
Opioids
BDNF
Depression
Addiction
Neurodegeneration
Cognition
Habituation
Coping
Adaptation
Microglia

Cited by (0)